Concepedia

Matthias Kopp

MK

Statistics

Publications

80

Citations

4.6K

H-Index

38

Active since

1997

Affiliations

German Center for Lung Research(Current)

University of Lübeck

Medizinische Hochschule Hannover

University Hospital of Bern

University of Bern

Matthias Kopp is an author at German Center for Lung Research specializing in life sciences, immunology, and hypersensitivity.

ORCID

Publications per year

1997–2025

80

Publications

80

Randomized, Double-Blind, Placebo-Controlled Trial of Probiotics for Primary Prevention: No Clinical Effects of <i>Lactobacillus</i> GG Supplementation

Matthias Kopp, Isabell Hennemuth, Andrea Heinzmann et al. · PEDIATRICS · 2008 · 384 citations

, , +11

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases

Oliver Pfaar, Claus Bachert, Albrecht Bufe et al. · Allergo Journal International · 2014 · 348 citations

, , +13

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co‐morbid seasonal allergic asthma

Matthias Kopp, Eckard Hamelmann, Stefan Zielen et al. · Clinical & Experimental Allergy · 2008 · 178 citations

, , +17

Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update

Johannes Ring, Kirsten Beyer, Tilo Biedermann et al. · Allergo Journal International · 2021 · 152 citations · Full text

, , +12

Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease

Markus Weckmann, Adam Collison, Jodie L. Simpson et al. · Nature Medicine · 2007 · 125 citations

, , +16

1–5 of 80